Standard Life (LON:SDLF – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Berenberg Bank in a research note issued to investors on Monday, Digital Look reports. They currently have a GBX 1,072 target price on the stock. Berenberg Bank’s price target suggests a potential upside of 15.52% from the company’s previous close.
Other analysts also recently issued research reports about the stock. JPMorgan Chase & Co. raised their price target on shares of Standard Life from GBX 975 to GBX 1,075 and gave the company an “overweight” rating in a report on Thursday, August 13th. Royal Bank Of Canada raised shares of Standard Life to a “sector perform” rating and boosted their price objective for the company from GBX 870 to GBX 885 in a report on Monday, July 27th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Standard Life presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 968.
Read Our Latest Analysis on Standard Life
Standard Life Stock Up 0.9%
Standard Life (LON:SDLF – Get Free Report) last released its quarterly earnings data on Monday, September 7th. The company reported GBX (20.30) EPS for the quarter.
About Standard Life
Standard Life is a long-established provider of retirement, savings and investment products, historically known for life assurance, pensions and asset management. Its offerings have included workplace and personal pension plans, individual savings accounts (ISAs), annuities and a range of investment funds and wealth-management services aimed at both individual and institutional clients. The firm has traditionally distributed products through financial advisers, workplace channels and direct platforms.
Founded in 1825 and historically headquartered in Edinburgh, Standard Life built a strong presence in the U.K.
Read More
- Five stocks we like better than Standard Life
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits
Receive News & Ratings for Standard Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Standard Life and related companies with MarketBeat.com's FREE daily email newsletter.
